ALS PROGRAM

Shi Y, Hung ST, Rocha G, Lin S, Linares GR, Staats KA, Seah C, Wang Y, Chickering M, Lai J, Sugawara T, Sagare AP, Zlokovic BV, Ichida JK (2019) Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons. JCI Insight 4(15):e127736.

Winkler EA, Sengillo JO, Sagare AP, Zhao Z, Ma Q, Zuniga E, Wang Y, Zhong Z, Sullivan JS, Griffin JH, Cleveland DW, Zlokovic BV (2014) Blood-spinal cord barrier disruption contributed to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci U S A 111(11):E1035-42

Esmon CT, Glass JD (2009) The APCs of neuroprotection. 119 (11), 3205-3207

Zhong Z, Ilieva H, Hallagan L, Bell R, Singh I, Paquette N, Thiyagarajan M, Deane R, Fernandez JA, Lane S, Zlokovic AB, Liu T, Griffin JH, Chow N, Castellino FJ, Stojanovic K, Cleveland DW, Zlokovic BV (2009) Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD-1 in motor neurons and microglia cells. J Clin Invest. 119 (11), 3437-3449

Esmon CT, Glass JD (2009) The APCs of neuroprotection. 119 (11), 3205-3207. Full text